abstract |
The present invention relates to an antibody-drug-conjugate. In one aspect, the invention relates to an antibody-drug-conjugate comprising an antibody capable of binding to a target with at least one drug selected from derivatives of dolastatin 10 and auristatin conjugate. The invention also encompasses methods of treatment and the use of said antibody-drug-conjugates for the treatment of cancer. |